PORTUGUESE CLINICAL PRACTICE IN THE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER WITH EGFR EXON 20 INSERTION MUTATIONS

被引：0
|
作者：
Pinheiro, B. [1 ]
Carvalho, P. [1 ]
Silva Miguel, L. [1 ]
Rodrigues, A. [2 ]
Teixeira, E. [3 ]
Barata, F. [4 ]
da Luz, R. [5 ]
Hespanhol, V [6 ]
Lopes, R. [7 ]
Santos, S. [7 ]
Borges, M. [1 ]
机构：
[1] Evigrade Healthcare Res & Consulting, Lisbon, Portugal
[2] Inst Portugues Oncol Porto, Serv Oncol, Porto, Portugal
[3] Ctr Hosp Univ Lisboa Norte, Serv Pneumol, Lisbon, Portugal
[4] Ctr Hosp & Univ Coimbra, Serv Oncol, Coimbra, Portugal
[5] Ctr Hosp & Univ Lisboa Cent, Serv Oncol, Lisbon, Portugal
[6] Ctr Hosp Univ S Joao, Serv Pneumol, Porto, Portugal
[7] Janssen Portugal, Lisbon 15, Portugal
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HSD65
引用
收藏
页码：S286 / S286
页数：1
相关论文
共 50 条
  • [1] Clinical Outcomes of EGFR Exon 20 Insertion Mutations in Advanced Non-small Cell Lung Cancer in Korea
    Byeon, Seonggyu
    Kim, Youjin
    Lim, Sung Won
    Cho, Jang Ho
    Park, Sehoon
    Lee, Jiyun
    Sun, Jong-Mu
    Choi, Yoon-La
    Lee, Se-Hoon
    Ahn, Jin Seok
    Park, Keunchil
    Ahn, Myung-Ju
    [J]. CANCER RESEARCH AND TREATMENT, 2019, 51 (02): : 623 - 631
  • [2] EGFR exon 20 insertion mutations in non-small cell lung cancer
    Wang, Fenfang
    Li, Chenghui
    Wu, Qihuan
    Lu, Hongyang
    [J]. TRANSLATIONAL CANCER RESEARCH, 2020, 9 (04) : 2982 - 2991
  • [3] EGFR Exon 20 Insertion Mutations: Clinicopathological Characteristics and Treatment Outcomes in Advanced Non-Small Cell Lung Cancer
    Leal, Jose Luis
    Alexander, Marliese
    Itchins, Malinda
    Wright, Gavin M.
    Kao, Steven
    Hughes, Brett G. M.
    Pavlakis, Nick
    Clarke, Stephen
    Gill, Anthony J.
    Ainsworth, Hannah
    Solomon, Benjamin
    John, Thomas
    [J]. CLINICAL LUNG CANCER, 2021, 22 (06) : E859 - E869
  • [4] Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer
    Simon Vyse
    Paul H. Huang
    [J]. Signal Transduction and Targeted Therapy, 4
  • [5] Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer
    Vyse, Simon
    Huang, Paul H.
    [J]. SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2019, 4 (1)
  • [6] New therapies in non-small cell lung cancer with EGFR exon 20 insertion mutations
    David, Gil-Sierra Manuel
    del Pilar, Briceno-Casado Maria
    Cristina, Moreno-Ramos
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (04) : 934 - 943
  • [7] Current status and breakthroughs in treating advanced non-small cell lung cancer with EGFR exon 20 insertion mutations
    Hu, Meng
    Zhong, Congying
    Wang, Jiabing
    Chen, JinQin
    Zhou, Tao
    [J]. FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [8] Amivantamab for the treatment of EGFR exon 20 insertion mutant non-small cell lung cancer
    Vyse, Simon
    Huang, Paul H.
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (01) : 3 - 16
  • [9] Real-world clinical treatment outcomes in Chinese non-small cell lung cancer with EGFR exon 20 insertion mutations
    Shi, Chao
    Xing, Ruyue
    Li, Mengmeng
    Feng, Junnan
    Sun, Rui
    Wei, Bing
    Guo, Yongjun
    Ma, Jie
    Wang, Huijuan
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [10] CLINICAL CHARACTERISTICS OF NON-SMALL CELL LUNG CANCER WITH EGFR GENE MUTATIONS IN EXON 20
    Miyanaga, A.
    Akagi, K.
    Takeuchi, S.
    Kurimoto, F.
    Iijima, Y.
    Yoshino, N.
    Mikami, I.
    Akiyama, H.
    Sakai, H.
    [J]. LUNG CANCER, 2009, 64 : S54 - S54
12345